Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. [electronic resource]
Producer: 20031205Description: 497-504 p. digitalISSN:- 0198-8859
- Antiviral Agents -- therapeutic use
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Epitopes
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Prospective Studies
- Ribavirin -- therapeutic use
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.